Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on delivering high-quality products to improve patient care, announced today the FDA has approved a ...

Pharmaceuticals announced the FDA has approved a supplemental New Drug Application for its Acetadote product. Acetadote is an ...

FDA approval of Acetadote's simplified dosing propels Cumberland Pharmaceuticals' stock to a 90% single-day surge ...

The newly approved regimen is expected to simplify administration and potentially reduce medication errors and dose-related reactions.

Cumberland Pharmaceuticals Inc. (CPIX), a specialty pharmaceutical company, Tuesday, announced that its supplemental New Drug ...

Shares of Cumberland Pharmaceuticals were trading higher in the after-hours market after the company said the Food and Drug Administration approved a supplemental new drug application for liver drug ...

Shares of Cumberland Pharmaceuticals (CPIX) doubled on Tuesday morning, reaching levels not seen since March 2023, following ...

Today, the board of directors of Eli Lilly and Company approved a new $15 billion share repurchase program. The company's prior $5 billion share repurchase program was completed in the fourth quarter ...

A research team led by the University of Liverpool has developed an innovative new technique that can rapidly assess ...

Hologic, Inc. announced today that Martin Madaus has been elected to the Company's Board of Directors, effective December 6, 2024. Dr. Madaus was also appointed to the Compensation Committee and the ...

Researchers have demonstrated the clinical validity of a new mass spectrometry technology-based technique that can test a ...